195 results on '"Wraith, David C"'
Search Results
2. Symptoms and risk factors for long COVID in non-hospitalized adults
3. Antigen-specific immunotherapy with apitopes suppresses generation of FVIII inhibitor antibodies in HLA-transgenic mice
4. SARS-CoV-2 infection is associated with anti-desmoglein 2 autoantibody detection
5. Negative Selection during the Peripheral Immune Response to Antigen
6. SARS-CoV-2 Spike- and Nucleoprotein-Specific Antibodies Induced After Vaccination or Infection Promote Classical Complement Activation
7. SARS‐CoV‐2‐specific IgG1/IgG3 but not IgM in children with Pediatric Inflammatory Multi‐System Syndrome
8. Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study)
9. CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the TCR repertoire
10. CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice
11. Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis
12. A Role for Galanin in Human and Experimental Inflammatory Demyelination
13. Enhanced Selection of FoxP3⁺ T-Regulatory Cells Protects CTLA-4-Deficient Mice from CNS Autoimmune Disease
14. Antigen and checkpoint receptor engagement recalibrates T cell receptor signal strength
15. Induction of Tolerance to Therapeutic Proteins With Antigen-Processing Independent T Cell Epitopes: Controlling Immune Responses to Biologics
16. Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response
17. Extra-thymically induced T regulatory cell subsets: the optimal target for antigen-specific immunotherapy
18. A Single Amino Acid Change in a Myelin Basic Protein Peptide Confers the Capacity to Prevent Rather than Induce Experimental Autoimmune Encephalomyelitis
19. Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection
20. Development of a high‐sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS‐CoV‐2 spike glycoprotein in serum and saliva
21. The Mechanism of Action of Antigen Processing Independent T Cell Epitopes Designed for Immunotherapy of Autoimmune Diseases
22. The adaptive immune system in diseases of the central nervous system
23. A LAT-Based Signaling Complex in the Immunological Synapse as Determined with Live Cell Imaging is Less Stable in T Cells with Regulatory Capability
24. Nr4a1 and Nr4a3 Reporter Mice Are Differentially Sensitive to T Cell Receptor Signal Strength and Duration
25. Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases
26. Chromatin Priming Renders T Cell Tolerance-Associated Genes Sensitive to Activation below the Signaling Threshold for Immune Response Genes
27. IL-4 enhances IL-10 production in Th1 cells: implications for Th1 and Th2 regulation
28. Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs
29. Avidity and the Art of Self Non-Self Discrimination
30. Experimental autoimmune encephalomyelitis in mice expressing the autoantigen MBP1–10 covalently bound to the MHC class II molecule I-Au
31. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein
32. Differential activation of signal transducer and activator of transcription (STAT)3 and STAT5 and induction of suppressors of cytokine signalling in Th1 and Th2 cells
33. Peptides containing a dominant T-cell epitope from red cell band 3 have in vivo immunomodulatory properties in NZB mice with autoimmune hemolytic anemia
34. TUNING THE PERIPHERAL IMMUNE RESPONSE TO ANTIGEN.
35. USING ALTERED PEPTIDE LIGANDS TO ASSESS THE LIMITS OF T-CELL PROMISCUITY
36. Protein kinase C theta is required for efficient induction of IL-10-secreting T cells
37. Immunotherapy With Apitopes Blocks the Immune Response to TSH Receptor in HLA-DR Transgenic Mice
38. Variant proteins stimulate more IgM+ GC B-cells revealing a mechanism of cross-reactive recognition by antibody memory
39. Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis
40. The Future of Immunotherapy: A 20-Year Perspective
41. Myeloid‐derived suppressor cells mediate tolerance induction in autoimmune disease
42. Glycogen synthase kinase-3 controls IL-10 expression in CD4+ effector T-cell subsets through epigenetic modification of the IL-10 promoter
43. Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy
44. Tr1-Like T Cells – An Enigmatic Regulatory T Cell Lineage
45. Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS
46. Epigenetic modification of the PD-1 (Pdcd1) promoter in effector CD4+ T cells tolerized by peptide immunotherapy
47. Th1 Cells Facilitate the Entry of Th17 Cells to the Central Nervous System during Experimental Autoimmune Encephalomyelitis
48. CD86 Has Sustained Costimulatory Effects on CD8 T Cells1
49. CTLA-4 Modulates the Differentiation of Inducible Foxp3+ Treg Cells but IL-10 Mediates Their Function in Experimental Autoimmune Encephalomyelitis
50. Modification of the FoxP3 Transcription Factor Principally Affects Inducible T Regulatory Cells in a Model of Experimental Autoimmune Encephalomyelitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.